Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Change in Accured Expenses (2016 - 2026)

Innoviva filings provide 16 years of Change in Accured Expenses readings, the most recent being -$14.6 million for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses fell 462.69% to -$14.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$17.2 million, a 180.64% decrease, with the full-year FY2025 number at -$1.8 million, down 159.26% from a year prior.
  • Change in Accured Expenses hit -$14.6 million in Q3 2025 for Innoviva, down from $2.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $9.7 million in Q2 2022 to a low of -$14.6 million in Q3 2025.
  • Median Change in Accured Expenses over the past 5 years was -$2.5 million (2021), compared with a mean of -$1.3 million.
  • The widest YoY moves for Change in Accured Expenses: up 4370.48% in 2022, down 1313.66% in 2022.
  • Innoviva's Change in Accured Expenses stood at -$2.5 million in 2021, then soared by 31.2% to -$1.7 million in 2022, then tumbled by 106.32% to -$3.5 million in 2023, then grew by 26.57% to -$2.6 million in 2024, then crashed by 462.69% to -$14.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$14.6 million (Q3 2025), $2.6 million (Q2 2025), and -$2.6 million (Q1 2025) per Business Quant data.